2025 ICD-10-PCS Procedure Code XW03357
Introduction of Narsoplimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7 Code History
Introduction of Narsoplimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7 Code History
Introduction of Cefepime-taniborbactam Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 10 Code History
Introduction of Bentracimab, Ticagrelor Reversal Agent into Peripheral Vein, Percutaneous Approach, New Technology Group 10 Code History
Introduction of Durvalumab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 6 Code History
Introduction of Nerinitide into Peripheral Vein, Percutaneous Approach, New Technology Group 6 Code History
Introduction of Spesolimab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 8 Code History
Introduction of Brexanolone into Peripheral Vein, Percutaneous Approach, New Technology Group 6 Code History
Introduction of Engineered Allogeneic Thymus Tissue into Muscle, Open Approach, New Technology Group 8 Code History